Lv21
120 积分 2025-05-13 加入
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
7天前
已完结
Design and Development of DNA Damage Chemical Inducers of Proximity for Targeted Cancer Therapy
7天前
已完结
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
1个月前
已完结
Emerging trends in the global burden of colorectal cancer
1个月前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
1个月前
已完结
Targeting thymine DNA glycosylase induces synthetic lethality in p53-deficient cancers
1个月前
已完结
Targeting claudins in cancer
1个月前
已完结
Claudin proteins as emerging therapeutic targets for solid tumours
1个月前
已完结
Mechanisms of Response and Resistance to PSMA×CD3 Bispecifics in CD34+ Humanized Mice
1个月前
已完结
Giredestrant reverses progesterone hypersensitivity driven by estrogen receptor mutations in breast cancer
1个月前
已完结
皖公网安备34019202002308
